Seatbelts in CAR therapy: How Safe Are CARS?-Reference-Cited by-同舟云学术

Seatbelts in CAR therapy: How Safe Are CARS?

Published:2015-05-08 Issue:2 Volume:8 Page:230-249
ISSN:1424-8247
Container-title:Pharmaceuticals
language:en
Short-container-title:Pharmaceuticals

Author:

Minagawa Kentaro,Zhou Xiaoou,Mineishi Shin,Di Stasi Antonio

Publisher

MDPI AG

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

http://www.mdpi.com/1424-8247/8/2/230/pdf

Reference92 articles.

1. Hematopoietic stem-cell transplantation;Copelan;New Engl. J. Med.,2006

2. Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches

3. Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?;Ringden;Br. J. Haematol.,2000

4. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic t lymphocyte-defined non-mhc antigens;De Bueger;J. Immunol.,1992

5. Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens;Warren;Blood,2010

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Chimeric Antigen Receptor T Cell Therapy for Hepatocellular Carcinoma;E3S Web of Conferences;2024

2. Safety Switches Used for Cellular Therapies;Cancer Drug Discovery and Development;2022

3. Immunotherapy and radiation for high-grade glioma: a narrative review;Translational Cancer Research;2021-05

4. Recent advances in breast cancer immunotherapy: The promising impact of nanomedicines;Life Sciences;2021-04

5. Combination of CD19 and CD22 CAR‐T cell therapy in relapsed B‐cell acute lymphoblastic leukemia after allogeneic transplantation;American Journal of Hematology;2021-03-29